Polar Capital LLP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Polar Capital LLP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$10,754,000
-77.7%
260,703
-73.8%
0.08%
-80.8%
Q2 2020$48,257,000
-10.4%
995,614
-21.9%
0.42%
-27.9%
Q1 2020$53,842,000
+62.5%
1,274,366
+64.6%
0.58%
+100.7%
Q4 2019$33,128,000
+2099.7%
774,378
+1448.8%
0.29%
+1700.0%
Q4 2017$1,506,000
-46.7%
50,000
-33.3%
0.02%
-50.0%
Q3 2017$2,825,000
-42.1%
75,000
-57.1%
0.03%
-51.5%
Q2 2017$4,881,000
-18.9%
175,0000.0%0.07%
-26.7%
Q1 2017$6,017,000
+942.8%
175,000
+775.0%
0.09%
+900.0%
Q4 2016$577,000
+61.2%
20,000
+77.8%
0.01%
+50.0%
Q3 2016$358,000
-63.7%
11,250
-63.0%
0.01%
-68.4%
Q2 2016$987,000
+89.8%
30,393
+108.2%
0.02%
+111.1%
Q4 2015$520,000
-26.2%
14,595
-31.6%
0.01%
-35.7%
Q3 2015$705,000
-44.7%
21,333
-30.0%
0.01%
-44.0%
Q2 2015$1,276,000
+51.2%
30,475
+17.7%
0.02%
+56.2%
Q1 2015$844,000
+13.0%
25,898
+10.0%
0.02%
+6.7%
Q4 2014$747,000
+250.7%
23,542
+173.5%
0.02%
+275.0%
Q3 2014$213,0008,6090.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders